Skip to main content

Ets2 anchors the prometastatic function of mutant p53 in osteosarcoma.

Author(s): Liu, Daniel D; Kang, Yibin

To refer to this page use:
Abstract: Mutations in the tumor suppressor p53 occur in a majority of human cancers. Some gain-of-function (GOF) p53 mutations endow tumor cells with increased metastatic ability, although our understanding of the underlying mechanism remains incomplete. In this issue of Genes & Development, Pourebrahim and colleagues (pp. 1847-1857) develop a new mouse model of osteosarcoma in which a GOF mutant p53 allele is expressed specifically in osteoblasts, while the tumor microenvironment remains wild type for p53, allowing for the study of cell-autonomous functions. In this model, the role of GOF mutant p53 in promoting lung metastasis is shown to be critically dependent on the transcription factor Ets2 and is accompanied by the elevated expression of a cluster of small nucleolar RNAs (snoRNAs).
Publication Date: Sep-2017
Citation: Liu, Daniel D, Kang, Yibin. (2017). Ets2 anchors the prometastatic function of mutant p53 in osteosarcoma.. Genes & development, 31 (18), 1823 - 1824. doi:10.1101/gad.307439.117
DOI: doi:10.1101/gad.307439.117
ISSN: 0890-9369
EISSN: 1549-5477
Pages: 1 - 3
Language: eng
Type of Material: Journal Article
Journal/Proceeding Title: Genes & development
Version: Final published version. This is an open access article.

Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.